Edinburgh-based biotechnology company Cytomos has appointed senior life sciences executive Dr Alex Jones as non-executive director, as it looks to accelerate the commercialisation of its cell analysis technology. Dr Jones brings extensive expertise in life science tools and cell and gene therapy. As the incumbent CEO of Cellply, and previously… Read More
TechBio Cytomos has launched a new benchtop cell analyser called Celledonia, which uses the company’s AuraCyt platform. Celledonia has been designed to provide cell-specific insights for modalities including monoclonal antibodies (mAbs), T cell immunotherapies, and induced pluripotent stem cells (iPSCs). The new technology could… Read More
Scotland-based biotech Cytomos has launched its newly patented AuraCyt cell analysis technology brand. According to the company, AuraCyt provides information on cell properties and can be incorporated in-line, allowing real-time monitoring of cell manufacturing events and predicting manufacturing success. It is designed to collect data that… Read More
